Appointment New Patient Appointment or 214-645-8300

More Blogs


Claus Roehrborn, M.D.

What We Know About Your Prostate

Prostate cancer genomic testing is flawed: Three reasons why

Men with prostate cancer want to know the future: Will my cancer get worse? Do I need surgery? Genomic testing can help us make educated recommendations, but it’s far from perfect. Claus Roehrborn, M.D., explains why genomic testing isn’t a “crystal ball” for predicting prostate cancer risk.

Hormone therapy helps some prostate cancer survivors live longer

After prostate gland removal, cancer returns in up to 30% of men. But a 2017 study found that hormone-blockers plus radiation can prevent recurrence.

PSA tests: Can they save men from prostate cancer?

PSA blood tests are controversial in screening for prostate cancer. But Dr. Roehrborn says they save lives.

UTSW teams exceed 1,000 targeted prostate biopsies

Dr. Claus Roehrborn and colleagues in Urology and Radiology are using a new, targeted biopsy method for prostate cancer that’s more effective than standard biopsies – and they’ve just reached a significant milestone.